Скачать или смотреть Cardinal Health Reported Mixed Q1 Results, Believes It Will Achieve Higher End Of EPS For The Year

"Cardinal Health (NYSE:CAH) reported fiscal Q1 adjusted EPS of $0.64, ahead of consensus estimates of $0.53 per share. Revenues for the quarter fell 1% year-over-year to $24.4 billion, missing consensus estimates of $25.1 billion.

George Barrett, chairman and chief executive officer of Cardinal Health said, ""Our first quarter was an excellent start to the year, These results reflect the progress we have made in our Pharmaceutical Segment, specifically in the work we have been doing to improve margins across that segment by strengthening our generics programs and expanding our retail independent pharmacy customer base. Our Medical Segment declined as we had expected, largely as a result of unique events in the prior-year period and commodity price increases. Although medical procedures remained somewhat soft during the period, we continue to make great progress in our program to position our medical businesses to serve the needs of these evolving markets. Given the strong start to the year for our Pharmaceutical Segment and the progress we project on various company-wide initiatives, we have become more confident in achieving the higher end of our non-GAAP diluted EPS guidance range of $2.38 to $2.48,"" Barrett said."